论文信息 - Empagliflozin does not affect left ventricular diastolic function in patients with type 2 diabetes mellitus and coronary artery disease: insight from the EMPA-HEART CardioLink-6 randomized clinical trial - 字舞流文

Empagliflozin does not affect left ventricular diastolic function in patients with type 2 diabetes mellitus and coronary artery disease: insight from the EMPA-HEART CardioLink-6 randomized clinical trial

S. Verma | M. Ng | A. Yan | I. Roifman | K. Connelly | C. Mazer | H. Teoh | V. Ramanan | L. Jimenez-Juan | D. Deva | M. Pourafkari | A. Quan | Archana Rai | Yin Ge | S. Verma